Findings

What do systematic reviews say?

3,696 questions · 3,815 findings · 855 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 573 · 15%GRADE not reported 374 · 9.8%Very low 993 · 26%Low 1,062 · 27.8%Moderate 614 · 16.1%High 199 · 5.2%

Preoperative vessel imaging by ultrasound mapping vs standard preoperative care

Rate of interventions required to maintain patency (per 1000 patient‐days) · people with ESRD receiving haemodialysis through an arteriovenous fistula

1 finding from 1 review

Preoperative vascular access evaluation for haemodialysis patients 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 70 participants
Very low

Early vs late tracheostomy

Ventilator‐free days up to day 28 · critically ill patients

1 finding from 1 review

Early versus late tracheostomy for critically ill patients 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 335 participants
Moderate

Early vs late tracheostomy

Days of MV during 1 to 60 days · critically ill patients

1 finding from 1 review

Early versus late tracheostomy for critically ill patients 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 336 participants
Very low

Early vs late tracheostomy

ICU discharge (at day 28 after randomization) · critically ill patients

Early leads to higher ICU discharge (at day 28 after randomization) compared with late tracheostomy (high certainty).

1 finding from 1 review

Early versus late tracheostomy for critically ill patients 2015 · Cochrane Headline outcomes only
RR 1.29 [1.08, 1.55]
2 studies · 538 participants
High

Paroxetine vs placebo

Frequency of use % of heavy drinking days at the end of treatment · people with anxiety and comorbid alcohol use disorders

1 finding from 1 review

Pharmacotherapy for anxiety and comorbid alcohol use disorders 2015 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Paroxetine vs placebo

Percent of days abstinent · people with anxiety and comorbid alcohol use disorders

1 finding from 1 review

Pharmacotherapy for anxiety and comorbid alcohol use disorders 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 54 participants
Very low

Paroxetine vs placebo

Drinks per drinking day · people with anxiety and comorbid alcohol use disorders

1 finding from 1 review

Pharmacotherapy for anxiety and comorbid alcohol use disorders 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 54 participants
Very low

Antibiotics (short duration) vs prolonged‐course antibiotic therapy be used

28‐day antibiotic‐free days · hospital‐acquired pneumonia

1 finding from 1 review

Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 431 participants
Low

Fresh frozen plasma vs no plasma

Short‐term mortality (up to 30 days) · Neonates, children and adults undergoing cardiovascular surgery

1 finding from 1 review

Fresh frozen plasma for cardiovascular surgery 2015 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 287 participants
Very low

Chronic disease management vs usual care

Days off work · adults with asthma

The review found no eligible studies for this question.

1 finding from 1 review

Chronic disease management programmes for adults with asthma 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Milnacipran 100 mg/day · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
100 participants
GRADE not reported

Intervention not reported

Milnacipran 200 mg/day · adults with fibromyalgia

1 finding from 1 review

Milnacipran for pain in fibromyalgia in adults 2015 · Cochrane Headline outcomes only
no estimate extracted
200 participants
GRADE not reported

Positive pressure therapy vs placebo

Proportion of days with vertigo in 4 weeks: vertigo scores > 2 · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 62 participants
Moderate

Positive pressure therapy vs placebo

Vertigo days in 4 months: vertigo scores > 2 · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Moderate

Positive pressure therapy vs placebo

Days of sick‐leave at 1 year · Ménière’s disease

1 finding from 1 review

Positive pressure therapy for Ménière's disease or syndrome 2015 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 125 participants
Moderate

Any growth factor vs placebo or no growth factor

Ulcer‐free days following treatment for diabetic foot ulcers (free from any recurrence) · people with diabetes and foot ulcers

1 finding from 1 review

Growth factors for treating diabetic foot ulcers 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 55 participants
GRADE not reported

Lidocaine vs disopyramide

Overall survival at 30 days after myocardial infarction · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs tocainide

Overall survival at 30 days after myocardial infarction · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs mexiletine

Overall survival at 30 days after myocardial infarction · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs propafenone

Overall survival at 30 days after myocardial infarction · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found